Identification of Cytochrome P450 Isoforms Involved in the Metabolism of Paroxetine and Estimation of Their Importance for Human Paroxetine Metabolism Using a Population-Based Simulator

@article{Jornil2010IdentificationOC,
  title={Identification of Cytochrome P450 Isoforms Involved in the Metabolism of Paroxetine and Estimation of Their Importance for Human Paroxetine Metabolism Using a Population-Based Simulator},
  author={J. Jornil and K. G. Jensen and Frank Larsen and K. Linnet},
  journal={Drug Metabolism and Disposition},
  year={2010},
  volume={38},
  pages={376 - 385}
}
  • J. Jornil, K. G. Jensen, +1 author K. Linnet
  • Published 2010
  • Chemistry, Medicine
  • Drug Metabolism and Disposition
    • We identify here for the first time the low-affinity cytochrome P450 (P450) isoforms that metabolize paroxetine, using cDNA-expressed human P450s measuring substrate depletion and paroxetine-catechol (product) formation by liquid chromatography-tandem mass spectrometry. CYP1A2, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 were identified as paroxetine-catechol-forming P450 isoforms, and CYP2C19 and CYP2D6 were identified as metabolizing P450 isoforms by substrate depletion. Michaelis-Menten constants Km… CONTINUE READING
    View on Publisher
    dmd.aspetjournals.org
    60 Citations
    Highly Influencial Citations
    5
    Background Citations
    16
    Methods Citations
    2

    Tables and Topics from this paper

    Tables

    Explore Further: Topics Discussed in This Paper

    60 Citations
    Citation Type

    Citation Type

    Predicted contributions of cytochrome P450s to drug metabolism in human liver microsomes using relative activity factor were dependent on probes
    • S. Wang, Xiange Tang, +4 authors L. Liu
    • Chemistry, Medicine
    • Xenobiotica; the fate of foreign compounds in biological systems
    • 2019
    • 2
    Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis
    • 1
    Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems
    • 7
    Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
    • 6
    A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP 2 D 6 and CYP 1 A 2 Metabolized Drugs in Pregnant Women s
    • 1
    • Highly Influenced
    • PDF
    A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women
    • 63
    • PDF
    The quasi-irreversible inactivation of cytochrome P450 enzymes by paroxetine: a computational approach.
    Evaluation of Hepatic Disposition of Paroxetine Using Sandwich-Cultured Rat and Human Hepatocytes
    • 12
    • PDF
    Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors
    • 24
    Application of a novel regulatable Cre recombinase system to define the role of liver and gut metabolism in drug oral bioavailability
    • 12
    • PDF

    References

    SHOWING 1-10 OF 33 REFERENCES
    The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.
    • 115
    • Highly Influential
    NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    • 53
    Roles of polymorphic enzymes CYP2D6 and CYP2C19 for in vitro metabolism of amitriptyline at therapeutic and toxic levels
    • 5
    Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
    • 191
    • PDF
    Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine.
    • 224
    • Highly Influential
    • PDF
    Drugs as CYP3A Probes, Inducers, and Inhibitors
    • 162
    Metoprolol-paroxetine interaction in human liver microsomes: stereoselective aspects and prediction of the in vivo interaction.
    • 30
    Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions
    • 351
    • Highly Influential
    • PDF
    Gas chromatographic-mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi derivatization using S-adenosylmethionine.
    • 19
    In vitro‐in vivo extrapolation of CYP2D6 inactivation by paroxetine: prediction of nonstationary pharmacokinetics and drug interaction magnitude
    • 32
    • Highly Influential